RESISTANCE MUTATIONS TO INTEGRASE INHIBITORS AND HIV-1 SUBTYPES IN PREGNANT WOMEN LIVING WITH HIV IN RIO DE JANEIRO, 2018–2024
Introduction: Since 2017, dolutegravir (DTG), a second-generation integrase inhibitor (INI) with a high genetic barrier, has been part of first-line HIV treatment together with tenofovir and lamivudine. Resistance mutations (RMs) to this regimen are rare. In a recent systematic review, RM rates amon...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2026-03-01
|
| Serier: | Brazilian Journal of Infectious Diseases |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S1413867026002278 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|